Literature DB >> 10920426

[Dementia caused by neurosyphilis: clinical and neuropsychological follow-up of a patient].

A P Vargas1, F J Carod-Artal, M C Del Negro, M P Rodrigues.   

Abstract

Dementia is one of the manifestations of late syphilis and it is characterized by cognitive deterioration and behaviour disturbances. We report on a male patient with cognitive decline, behaviour disorder, hyperactivity, hallucinations, short-term memory and Argyll Robertson pupils due to neurosyphilis. Minimental state test (MST) was 16. Cerebrospinal fluid (CSF) protein concentration was 82 mg/dl, CSF-leucocyte count 128 cells/mm3 (98% mononuclear cells), CSF-VDRL 1:4, and CSF-T.pallidum haemaglutination assay 1:2560. MRI showed no cerebral alteration, but SPECT revealed left fronto-temporal hypocaptation. He received intravenous penicillin. MST done 3 months after the treatment scored 22. A new spinal tap showed normal CSF. Neurosyphilis should be part of the differential diagnosis of every patient showing cognitive deterioration and behaviour disturbances. During follow-up, MMS is an useful instrument to ++measure cognitive decline and response to treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920426     DOI: 10.1590/s0004-282x2000000300029

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  4 in total

1.  [SPECT and FDG-PET in diagnostics of neurolues].

Authors:  Robert Pichler; Stefan Doppler; Elisabeth Szalay; Christine Hertl; Ulrich Knell; Johanna Winkler
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

2.  Neurosyphilis with dementia and bilateral hippocampal atrophy on brain magnetic resonance imaging.

Authors:  Shima Mehrabian; Margarita Raycheva; Martina Traykova; Tonya Stankova; Latchezar Penev; Olga Grigorova; Latchezar Traykov
Journal:  BMC Neurol       Date:  2012-09-20       Impact factor: 2.474

3.  Neurosyphilis presenting with dementia, chronic chorioretinitis and adverse reactions to treatment: a case report.

Authors:  Shima Mehrabian; Margarita Radoslavova Raycheva; Elena Petrova Petrova; Nikolay Konstantinov Tsankov; Latchezar Dintchov Traykov
Journal:  Cases J       Date:  2009-09-01

Review 4.  Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.

Authors:  Bruno Fonseca-Santos; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Int J Nanomedicine       Date:  2015-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.